Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2020-03-16 18:49:26
Bergen, Norway, 16 March 2020 - Annual general meeting of BerGenBio ASA was held at Clarion Hotel Bergen Airport, Flyplassveien 551, 5869 Bergen, on 16 March 2020. All proposals were resolved as presented in the notice convening the annual general meeting distributed on 24 February 2020, as further set out in the minutes from the annual general meeting attached hereto and available at https://www.bergenbio.com/investors/general-meetings/. For further information, please contact: Richard Godfrey CEO, BerGenBio ASA richard.godfrey@bergenbio.com +47 917 86 304 Rune Skeie CFO, BerGenBio ASA rune.skeie@bergenbio.com +47 917 86 513 Forward looking statements This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.